title: Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsy.
abstract: BACKGROUND
  Gamma knife (GK) radiosurgery has been proposed as an alternative to classic microsurgery in mesial temporal lobe epilepsy (MTLE). Short-term follow-up studies have reported encouraging results, but long-term efficacy is not known.
  
  
  OBJECTIVE
  To report the efficacy and tolerance of GK radiosurgery in MTLE after a follow-up > 5 years.
  
  
  METHODS
  Patients with a follow-up > 5 years presenting with MTLE and treated with a marginal dose of 24 Gy were included in the study.
  
  
  RESULTS
  Fifteen patients were included. Eight were treated on the left side, and 7 were treated on the right. The mean follow-up was 8 years (range 6-10 years). At the last follow-up, 9 of 16 patients (60%) were considered seizure free (Engel Class I) (4/16 in Class IA, 5/16 in Class IB). Seizure cessation occurred with a mean delay of 12 months (+/- 3) after GK radiosurgery, often preceded by a period of increasing aura or seizure occurrence (6/15 patients). The mean delay of appearance of the first neuroradiologic changes was 12 months (+/- 4). Nine patients (60%) experienced mild headache and were placed on corticosteroid treatment for a short period. All patients who were initially seizure free experienced a relapse of isolated aura (10/15, 66%) or complex partial seizures (10/15, 66%) during antiepileptic drug tapering. Restoration of treatment resulted in good control of seizures.
  
  
  CONCLUSIONS
  Gamma knife radiosurgery is an effective and safe treatment for mesial temporal lobe epilepsy. Results are maintained over time with no additional side effects. Long-term results compare well with those of conventional surgery.
authors.affiliation: Département de Neurophysiologie Clinique, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France. fbartolo@medecine.univ-mrs.fr
authors.forename: F
authors.initials: F
authors.lastname: Bartolomei
authors.forename: M
authors.initials: M
authors.lastname: Hayashi
authors.forename: M
authors.initials: M
authors.lastname: Tamura
authors.forename: M
authors.initials: M
authors.lastname: Rey
authors.forename: C
authors.initials: C
authors.lastname: Fischer
authors.forename: P
authors.initials: P
authors.lastname: Chauvel
authors.forename: J
authors.initials: J
authors.lastname: Régis
mesh_terms: D000328:Adult; D001284:Atrophy / Q000209:etiology / Q000473:pathology; D015331:Cohort Studies; D004351:Drug Resistance; D004833:Epilepsy, Temporal Lobe / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D011829:Radiation Dosage; D016634:Radiosurgery / Q000009:adverse effects / Q000592:standards / Q000706:statistics & numerical data*; D055502:Secondary Prevention; D013702:Temporal Lobe / Q000473:pathology / Q000503:physiopathology / Q000528:radiation effects; D013995:Time; D016896:Treatment Outcome; D014786:Vision Disorders / Q000209:etiology